Stocks
53962MWR
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare genetic diseases, with a focus on central nervous system disorders. Its lead programs target conditions with high unmet medical need, and investors track it for its pipeline milestones and potential regulatory approvals.
Congressional Interest in 53962 (MWR)
1 member of Congress has disclosed 1 trade in 53962 (MWR), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading MWR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-05-15 | JAMES B. RENACCI | sell | $1K-$15K |